Bennicas & Associates, Inc. Abbott Laboratories Transaction History

Bennicas & Associates, Inc.

$157 Million
Q4 2022

A detailed history of Bennicas & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 14,141 shares of ABT stock, worth $1.6 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

14,141

Previous 14,141 -0.0%

Holding current value

$1.6 Million

Previous $1.55 Million 0.06%

% of portfolio

0.99%

Previous 0.9%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$95.06 - $111.52 $19,012 - $22,304	-200 Reduced 1.39%	14,141 $1.55 Million
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 0.69%	14,341 $1.39 Million
Q1 2022 Apr 15, 2022	SELL	$114.02 - $139.04 $57,010 - $69,520	-500 Reduced 3.35%	14,441 $1.71 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $11,553 - $14,146	-100 Reduced 0.66%	14,941 $2.1 Million
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 1.31%	15,041 $1.78 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $54,420 - $64,114	-500 Reduced 3.18%	15,241 $1.83 Million
Q3 2020 Oct 15, 2020	BUY	$91.64 - $111.29 $53,426 - $64,882	583 Added 3.85%	15,741 $1.71 Million
Q2 2020 Jul 14, 2020	SELL	$76.57 - $98.0 $17,228 - $22,050	-225 Reduced 1.46%	15,158 $1.39 Million
Q1 2020 Apr 15, 2020	SELL	$62.82 - $91.86 $56,538 - $82,674	-900 Reduced 5.53%	15,383 $1.21 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $98,922 - $110,124	-1,260 Reduced 7.18%	16,283 $1.41 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $15,304 - $17,850	-210 Reduced 1.18%	17,543 $1.48 Million
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $13,112 - $14,854	-200 Reduced 1.11%	17,753 $1.28 Million
Q3 2018 Oct 17, 2018	BUY	$60.81 - $73.36 $3,648 - $4,401	60 Added 0.34%	17,953 $1.32 Million
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $17,271 - $19,062	-300 Reduced 1.65%	17,893 $1.09 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $25,498 - $27,298	-475 Reduced 2.54%	18,193 $1.04 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $897,184 - $1 Million	18,668	18,668 $996,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.

Account

Bennicas & Associates, Inc. Abbott Laboratories Transaction History